Latest news with #Rupees
Mint
7 hours ago
- Business
- Mint
Natco Pharma shares to be in focus on Thursday after ₹2,000 crore acquisition move. Details here
Pharmaceutical firm Natco Pharma's share price will be in focus of stock market investors on Thursday, 24 July 2025, after the company's board of directors approved the ₹ 2,000 crore acquisition move of a South African firm, according to an exchange filing. Natco Pharma will acquire over 5.16 crore shares of Adcock Ingram Holdings Ltd, South Africa, for a total investment cost of ₹ 2,000 crore, including the transaction cost and other expenses. 'To acquire 51,643,319 Shares (5,03,51,444 Ordinary Shares from public and 12,91,875 Treasury Shares/Fresh Issuance from Adcock Ingram Holdings Limited) at a cash offer of ZAR 75.00 (approximately US$ 4.27) per share, i.e., 35.75% (inclusive of prior to acquisition shareholding of 0.80%) of shares of the Adcock Ingram Holdings Ltd, South Africa, with a total investment cost of approx. ₹ 2000,00,00,000/- (Rupees Two Thousand Crores only) including the transaction cost and other expenses,' the company informed BSE through the filing. The company will also incorporate NATCO Pharma South Africa Proprietary Limited, with an investment of up to ₹ 2,100 crore. Natco Pharma share price closed 2.01% higher at ₹ 1,034.75 after Wednesday's stock market session, compared to ₹ 1,014.35 at the previous market close. The company announced the acquisition update after the market operating hours on 23 July 2025. The pharmaceutical company's shares have given stock market investors more than 41% returns in the last five years. However, the stock has lost 17.92% in the last one-year period. On a year-to-date (YTD) basis, the shares are down 26% in 2025, but are trading 18.96% higher in the last one-month period. Natco Pharma shares hit their 52-week high level at ₹ 1,638.35 on 12 September 2025, while the 52-week low level was at ₹ 660.05 on 7 April 2025, according to BSE data. The company's market capitalisation (M-Cap) stood at ₹ 18,533.39 crore as of the stock market close on Wednesday, 23 July 2025. Read all stories by Anubhav Mukherjee
Mint
8 hours ago
- Business
- Mint
Natco Pharma shares to be in focus on Thursday after ₹2,000 crore acquisition move. Details here
Pharmaceutical firm Natco Pharma's share price will be in focus of stock market investors on Thursday, 24 July 2025, after the company's board of directors approved the ₹ 2,000 crore acquisition move of a South African firm, according to an exchange filing. Natco Pharma will acquire over 5.16 crore shares of Adcock Ingram Holdings Ltd, South Africa, for a total investment cost of ₹ 2,000 crore, including the transaction cost and other expenses. 'To acquire 51,643,319 Shares (5,03,51,444 Ordinary Shares from public and 12,91,875 Treasury Shares/Fresh Issuance from Adcock Ingram Holdings Limited) at a cash offer of ZAR 75.00 (approximately US$ 4.27) per share, i.e., 35.75% (inclusive of prior to acquisition shareholding of 0.80%) of shares of the Adcock Ingram Holdings Ltd, South Africa, with a total investment cost of approx. ₹ 2000,00,00,000/- (Rupees Two Thousand Crores only) including the transaction cost and other expenses,' the company informed BSE through the filing. The company will also incorporate NATCO Pharma South Africa Proprietary Limited, with an investment of up to ₹ 2,100 crore. Natco Pharma share price closed 2.01% higher at ₹ 1,034.75 after Wednesday's stock market session, compared to ₹ 1,014.35 at the previous market close. The company announced the acquisition update after the market operating hours on 23 July 2025. The pharmaceutical company's shares have given stock market investors more than 41% returns in the last five years. However, the stock has lost 17.92% in the last one-year period. On a year-to-date (YTD) basis, the shares are down 26% in 2025, but are trading 18.96% higher in the last one-month period. Natco Pharma shares hit their 52-week high level at ₹ 1,638.35 on 12 September 2025, while the 52-week low level was at ₹ 660.05 on 7 April 2025, according to BSE data. The company's market capitalisation (M-Cap) stood at ₹ 18,533.39 crore as of the stock market close on Wednesday, 23 July 2025. Read all stories by Anubhav Mukherjee Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
&w=3840&q=100)
Business Standard
13 hours ago
- Business
- Business Standard
Aaron Industries jumps 7% as board approves bonus, record date for dividend
National Stock Exchange (NSE) listed Aaron Industries shares jumped 6.9 per cent, logging an intraday high at ₹424.95 per share. The stock gained after the company announced bonus shares in the proportion of 1:1 and fixed record date for final dividend. At 1:49 PM, Aaron Industries share price was trading 3.98 per cent higher at ₹413.05 per share on BSE. In comparison, the BSE Sensex rose 0.5 per cent to 82,598.03. The market capitalisation of the company stood at ₹433.28 crore. The 52-week high of the company stood at ₹430 per share, and the 52-week low was at ₹251.05. CATCH STOCK MARKET UPDATES TODAY LIVE Aaron Industries' bonus issue and other details The industrial products company's board has considered and recommended the issue of bonus shares in the proportion of 1:1 which means one bonus share of ₹10 each will be received for every existing share. "This is to inform you that the Board of Directors of the Company at their Meeting held on Wednesday, July 23, 2025, has considered and recommended the issue of Bonus Shares in the proportion of 1:1, i.e. 1 (One) new fully paid-up Bonus Equity Shares of ₹10/- (Rupees Ten only) each for every 1 (One) existing fully paid-up Equity Shares of ₹10/- (Rupees Ten only) each held by the eligible Members as on the Record Date, subject to the approval of Shareholders at the ensuing 12th Annual General Meeting of the Company scheduled to be held on Tuesday, August 19, 2025," the filing read. The board also approved the record date for the final dividend as Friday, August 8, 2025. In May 2025, Aaron's board had approved and recommended a final dividend at the rate of 12 per cent i.e. ₹1.2 per share of the face value of ₹10/- each. The dividend will be received if approved by the shareholders at the ensuing Annual General Meeting of the company. The 12th Annual General Meeting will be called and convened on Tuesday, August 19, 2025. The board also approved increasing the authorised share capital of the company from ₹11 crore, divided into 1,10,00,000 shares of ₹10 each to ₹21 crore, divided into 2,10,00,000 shares of ₹10.
New Straits Times
13 hours ago
- New Straits Times
Police bust porn scam syndicate, 57 arrested
KUALA LUMPUR: Police have uncovered a scam syndicate that distributed pornographic content under the guise of a registered company, following a raid conducted on July 1. The syndicate allegedly collected payments from users while providing only limited access to the content before disappearing. Bukit Aman Commercial Crime Investigation Department (CCID) director Datuk Rusdi Mohd Isa said 57 people, including 26 women, were arrested during a raid at a business premises along Jalan Tun Razak. "All of them are believed to be involved in a 'like and share' scam, promoting and managing pornographic websites targeting users in India. "The syndicate is estimated to rake in profits of about 61,200 Rupees (RM3,000) per day, or approximately 1.22 million Rupees (RM60,000) a month," he told reporters at the CCID headquarters today.
Mint
15 hours ago
- Business
- Mint
Realty stock Man Infraconstruction rebounds from intraday low; here's why
Realty stock Man Infraconstruction edged higher less than a per cent in Wednesday's trading session after the company announced that board has approved the conversion of 1,58,81,580 convertible warrants into equity shares. The realty stock opened at ₹ 179.85 apiece on National Stock Exchange (NSE) on Wednesday, as compared to previous close of ₹ 178.07 on Tuesday. At 9:45 am, Man Infraconstruction share price dipped over 1 per cent to hit an intraday low of ₹ 177.93, but quickly rebounded to trade at ₹ 179.77 per share. The company informed the exchanges, on July 22, that the board has approved the conversion of warrants into equity shares with a face value of ₹ 2 each on preferential basis to amount aggregating up to ₹ 1,84,62,33,675 at the rate of ₹ 116.25 per warrant. ' We wish to inform you that the Allotment Committee of the Board of Directors of Man Infraconstruction Limited Company'') at its Meeting held today i.e. July 22, 2025, considered and approved the conversion of 1,58,81,580 (One Crore Fifty Eight Lakhs Eighty One Thousand Five Hundred Eighty) convertible warrants into 1,58,81,580 (One Crore Fifty Eight Lakhs Eighty One Thousand Five Hundred Eighty) equity shares of face value of Rs. 2/- each, on preferential basis, upon receipt of an amount aggregating to Rs. 1,84,62,33,675/- (Rupees One Hundred Eighty Four Crore Sixty Two Lakhs Thirty Three Thousand Six Hundred Seventy Five only) at the rate of Rs. 116.25 per Warrant (being 75% of the issue price per Warrant) from the allottees pursuant to the exercise of their right of conversion of Warrants into Equity Shares in accordance with the provisions of SEBI,' the company said in the exchange filing. The company further added, ' The allotment has been made for cash, upon the receipt of the remaining exercise price of Rs. 116.25 per Share Warrant (being an amount equivalent to the 75% of the warrant exercise,price of Rs. 155/- per Warrant), aggregating to Rs. 1,84,62,33,675/- (Rupees One Hundred Eighty Four Crore Sixty Two Lakhs Thirty Three Thousand Six Hundred Seventy Five only).' After the allotment of the new equity shares, the company's total subscribed and paid-up share capital has increased from ₹ 77.56 crore (made up of 38.78 crore shares with a face value of ₹ 2 each) to ₹ 80.73 crore (made up of 40.37 crore shares with a face value of ₹ 2 each). Prabhudas Lilladher Advisory, Vivek Mahavir Jain, Forbes EMF, Minerva Ventures Fund were among the list of 50 allottees of the equity shares. Disclaimer: This story is for educational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.
